Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01796015
Other study ID # 2010.598
Secondary ID 2010-A00890-39
Status Completed
Phase N/A
First received
Last updated
Start date April 2011
Est. completion date February 2017

Study information

Verified date July 2018
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intracranial hypertension (ICH) is a mortality risk factor in severe traumatic brain injury (TBI), in purulent meningitis, in hepatic encephalopathy and in Reye's syndrome. It is also a risk factor for severe neurologic sequelae in survivors. Intracranial pressure (ICP) monitoring is likely to guide therapeutics, and certain research on adults or on children, suggest that IH therapeutic approach, for instance for bacterial meningitis, would improve the prognosis. Two monitoring techniques are currently recommended. They are reference methods for ICP measure :

- monitoring with intraventricular catheter,

- intra-parenchymal monitoring using optical fiber catheter. Non invasive methods have been suggested, including ultrasound measurement of optic nerve sheath diameter (ONSD) which is the most interesting one. The ONSD measured ultrasonically is correlated with ICP level in adults with severe TBI. A diameter over 5,9 mm predicts ICH within the first 24 hours. In children, ONSD average values have been worked out, and an ONSD increase is found in children suffering from hydrocephalus with IH and in children with TBI. ICH precocious detection is fundamental in children sensitive to ICH because their cerebral development is not finished yet. Difficulties met for ICP monitoring implementation in infants and its invasive nature are often disliked by clinicians. A non-invasive exam is then essential to allow a better care of children with ICH in intensive care unit.


Recruitment information / eligibility

Status Completed
Enrollment 230
Est. completion date February 2017
Est. primary completion date February 2017
Accepts healthy volunteers No
Gender All
Age group 2 Months to 16 Years
Eligibility Inclusion Criteria:

For the 97 patients:

- children from 2 months to 16 years

- in the intensive care unit

- TBI : moderate (GCS between 9 and 12) to severe (GCS <9), whatever the mechanism involved

- informed consent form signed by parents

Non inclusion Criteria:

- obesity (BMI > 97th percentile for the age)

- patient already under replacement therapy.

- patient taking AEDs

- patient with long-term systemic corticosteroid therapy

- history of neurological disease or learning difficulties

- no covered by a national health insurance

Study Design


Intervention

Other:
ONSD ultrasound
Description of the ONSD ultrasound: ONSD is measured 3 mm behind the globe and perpendicularly to the optic nerve axis (2 dimensions mode). For each optic nerve, 2 measures are performed: 1 sagittal and 1 transverse. The patient is positioned in 30° dorsal elevation. Gel is applied on the eyelid and a 7,5 MHz probe is used. At the same time and on the same side, a transcranial Doppler is performed using a 2 MHz probe placed on the temple. Are measured: systolic velocity, mean velocity, diastolic velocity, resistance index and pulsatility index. As ONSD measures cannot be done blinded (regarding ICP monitoring), a centralised evaluation (by 2 experts) of the recorded sonograms is planned.

Locations

Country Name City State
France Pediatric Critical Care Unit, Hôpital Femme Mère Enfant ,Hospices Civils de Lyon Bron Rhône Alpes
France Pediatric Critical Care Unit, CHU La Tronche Grenoble

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary (sensitivity and specificity of echographic measurement of ONSD) Sensitivity and specificity of echographic measurement of the ONSD (mean value of both eyes), taken 15 minutes ,before invasive ICP monitoring, regarding detection of ICH in children with neurological injury, as compared to reference method for ICH detection (ICP monitoring with intraventricular catheter). To determine diagnostic performance (sensitivity and specificity) of ICH thanks to ultrasound measurement of ONSD, (15 minutes ,before invasive ICP monitoring)
Secondary Secondary outcome (1. To draw learning curves before the study begins to find out the number of ultrasound measurement needed) value (mm) of the echographic ONSD measurement performed by the clinicians/interns (learning curve) compared to the value found by the trainer
mean value, standard deviation and quartiles of ONSD measures performed in a population of patients intubated, ventilated, sedated and without cerebral lesion (control group)
Correlation between echographic ONSD values (mean of the values) and invasive ICP monitoring values (taken same day)
Correlation between variations of ONSD measures and treatment effet on ICH
Comparison of diagnostic capacity of ONSD measurements depending on age, ICH etiology (bacterial meningitis, encephalitis meningitis, stroke, cerebral cerebral thrombophlebitis, TBI and patients from neurosurgery)
determine diagnostic capacity of the measures performed with transcranial Doppler (resistance index, pulsatility index, systolic, mean and diastolic velocities) in the different pathologies and compare them to ONSD values
1. To draw learning curves before the study begins to find out the number of ultrasound measurement needed (day 0)
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05591183 - CERENOVUS Neurothrombectomy Devices Registry
Recruiting NCT03685578 - CERENOVUS Neurothrombectomy Devices Registry
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Completed NCT02827825 - Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis
Recruiting NCT02077582 - Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability N/A
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Completed NCT01732679 - Sunnaas International Network´s Stroke Study N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT00311025 - Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications? Phase 1/Phase 2
Withdrawn NCT03804125 - A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Completed NCT05435404 - Qualitative Study Patient & Physician Experiences Botox COVID-19
Completed NCT03898960 - Post Marketing Study to Evaluate the NIMBUS Device
Not yet recruiting NCT06087094 - A Trial of HRS-7450 in Chinese Healthy Volunteers Phase 1
Completed NCT02207023 - Healthy Lifestyles After Stroke - Stroke Coach N/A
Active, not recruiting NCT02017574 - Motor Learning in Stroke Phase 0
Completed NCT01864382 - "Core Stability" Exercises to Improve Sitting Balance in Stroke Patients N/A
Completed NCT02002390 - Efficacy and Safety of FTY720 for Acute Stroke Phase 2
Recruiting NCT04447599 - Conjunctival and Retinal Vascularization and Small Vessel Disease N/A
Recruiting NCT04157179 - Cerebral Oxygen Metabolism in Children N/A